Glucagon-like peptide (GLP-1) medications are giving many people with type 2 diabetes a new approach for managing their condition. “It’s a pretty exciting time for type 2 diabetes treatment,” says Sherrie Singh-Bryan, PharmD, CDCES, a clinical pharmacist, member of the Obesity Medicine Association, and certified diabetic care and education specialist at Winn Army Community Hospital in Fort Stewart, Georgia.
With new treatment options often come new questions. “A lot of the journey is learning on the go,” says Beverly Tchang, MD, an endocrinologist and associate professor of clinical medicine at Weill Cornell Medicine in New York City and governing board member for The Obesity Society. That said, it helps to understand how they work, what to expect, and where they could fit into your overall diabetes management plan.
Thinking about adding a GLP-1 to your type 2 diabetes treatment plan? Take this assessment to see how much you know about these medications and whether you’re prepared to integrate one into your care plan.
